Publications by authors named "Sue Cheng"

Claim this Profile
R
Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis.
Joseph F Merola, Lyn Guenther, Charles Lynde, Kim A Papp, Lawrence Charles Parish, Sue Cheng

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Richard J Nowak, Michael Benatar, Emma Ciafaloni, James F Howard, M Isabel Leite, Sue Cheng

N Engl J Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
Joseph F Merola, Lawrence Charles Parish, Lyn Guenther, Charles Lynde, Jean-Philippe Lacour, Sue Cheng

J Am Acad Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet's Syndrome.
Philip J Mease, Gülen Hatemi, Maria Paris, Sue Cheng, Peter Maes

Am J Clin Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of apremilast on quality of life in Behçet's syndrome: analysis of the phase 3 RELIEF study.
Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, Doyoung Kim, Melike Melikoğlu, Sue Cheng

RMD Open· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study.
Mitsuhiro Takeno, Hiroaki Dobashi, Yoshiya Tanaka, Hajime Kono, Shouji Sugii, Sue Cheng

Mod Rheumatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, Do Young Kim, David Saadoun, Sue Cheng

Clin Exp Rheumatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis.
Peter C Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng

J Rheumatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
Gülen Hatemi, Alfred Mahr, Yoshiaki Ishigatsubo, Yeong-Wook Song, Mitsuhiro Takeno, Sue Cheng

N Engl J Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
Edwin DeJesus, Soundos Saleh, Sue Cheng, Dorina van der Mey, Corina Becker

Pulm Circ· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis.
Marc Trellu, Jean-Baptiste Fau, Pierre Cortez, Sue Cheng, Isabelle Paty

Br J Clin Pharmacol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy men.
Fabrice Hurbin, Xavier Boulenc, Nikki Daskalakis, Christine Farenc, Theresa Taylor, Sue Cheng

J Clin Pharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis